These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12506754)

  • 1. [Direct molecular analysis of single disseminated cancer cells: a prerequisite for the development of adjuvant therapies?].
    Klein CA
    Acta Med Austriaca Suppl; 2002; 59():10-3. PubMed ID: 12506754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [From single disseminated tumor cells to metastasis insights from molecular genetic analyses of single cells].
    Klein CA
    Verh Dtsch Ges Pathol; 2003; 87():158-64. PubMed ID: 16888908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the way to specifically targeting minimal residual disease?
    Gebauer G
    Breast Cancer Res; 2008; 10(5):112. PubMed ID: 18947365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genome analysis and cancer therapy].
    Tahara H
    Nihon Geka Gakkai Zasshi; 2005 Nov; 106(11):706-9. PubMed ID: 16304819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status in human breast cancer micrometastasis.
    Alix-Panabières C; Müller V; Pantel K
    Curr Opin Oncol; 2007 Nov; 19(6):558-63. PubMed ID: 17906452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Minimal residual disease in gastrointestinal tumors: tumor detection in bone marrow, blood and lymph nodes].
    Rosenberg R; Nekarda H; Thorban S; Siewert JR
    Acta Med Austriaca Suppl; 2002; 59():42-53. PubMed ID: 12506760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective.
    Heng HH; Bremer SW; Stevens JB; Ye KJ; Liu G; Ye CJ
    J Cell Physiol; 2009 Sep; 220(3):538-47. PubMed ID: 19441078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer micrometastasis and tumour dormancy.
    Wikman H; Vessella R; Pantel K
    APMIS; 2008; 116(7-8):754-70. PubMed ID: 18834417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stochastic gene expression, disruption of tissue averaging effects and cancer as a disease of development.
    Capp JP
    Bioessays; 2005 Dec; 27(12):1277-85. PubMed ID: 16299757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal residual disease as the target for immunotherapy and gene therapy of cancer (review).
    Bubeník J; Símová J
    Oncol Rep; 2005 Nov; 14(5):1377-80. PubMed ID: 16211312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis.
    Stoecklein NH; Klein CA
    Int J Cancer; 2010 Feb; 126(3):589-98. PubMed ID: 19795462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer.
    Stoecklein NH; Hosch SB; Bezler M; Stern F; Hartmann CH; Vay C; Siegmund A; Scheunemann P; Schurr P; Knoefel WT; Verde PE; Reichelt U; Erbersdobler A; Grau R; Ullrich A; Izbicki JR; Klein CA
    Cancer Cell; 2008 May; 13(5):441-53. PubMed ID: 18455127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Will knowledge of human genome variation result in changing cancer paradigms?
    Gottlieb B; Beitel LK; Trifiro M
    Bioessays; 2007 Jul; 29(7):678-85. PubMed ID: 17563087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal residual disease in solid neoplasia: New frontier or red-herring?
    Mordant P; Loriot Y; Lahon B; Castier Y; Lesèche G; Soria JC; Massard C; Deutsch E
    Cancer Treat Rev; 2012 Apr; 38(2):101-10. PubMed ID: 21612875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dormant tumor cells as a therapeutic target?
    Quesnel B
    Cancer Lett; 2008 Aug; 267(1):10-7. PubMed ID: 18384938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and transcript analysis of a novel wallaby (Macropus eugenii) basal-like breast cancer cell line.
    Sharp JA; Mailer SL; Thomson PC; Lefèvre C; Nicholas KR
    Mol Cancer; 2008 Jan; 7():1. PubMed ID: 18179684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?
    Lang JE; Hall CS; Singh B; Lucci A
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1463-72. PubMed ID: 17944570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.